MannKind adapting technology for coronavirus
Westlake Village-based MannKind became the latest company to turn its efforts toward treating the COVID-19 pandemic, with the announcement of a collaboration with a Los Angeles firm that aims to adapt its inhalable drug delivery technology to combat the respiratory infection. The company best known for its inhalable insulin product Afrezza said it would reorient Read More →
Tri-county stocks rebound from coronavirus selloff
Stocks regained some of their footing March 17, with the announcement of trillions of dollars in potential spending by the federal government, including direct payments to individuals. Goleta software developer AppFolio led the gains in the region with an almost 30 percent pop for the day, alongside moderate gains for other software firms. It was Read More →
MannKind revenue grows but so does net loss
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind doubles third quarter revenue, trims loss
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind triples second quarter revenues
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind partners with One Drop
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
MannKind partners with drug discount app GoodRx
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
